NeuropharmacologyNeurosciencePeer-reviewed journal article
The atypical antidepressant tianeptine causes opioid-receptor-dependent beta oscillations in the rat hippocampus
Scott G. Burt, Grant PhillipsiD, Jeremy J. LambertiD, Stephen J. MartiniD
Abstract
Introduction Introduction Materials and Methods Results Discussion Data availability Declaration of competing... References According to the 2021 Global Burden of Diseases study, major depressive disorder (MDD) is currently the second largest worldwide contributor to years lived with disability (Ferrari, Santomauro, et al., 2024), and its prevalence is growing rapidly, particularly among adolescents and young adults (Zhang et al., 2025). Current first-line pharmacological treatment typically involves selective serotonin reuptake inhibitors (SSRIs), but these drugs have variable efficacy, therapeutic benefits can take weeks to arise, and cessation of treatment can result in a distressing discontinuation syndrome (Sharp and Collin ...
- Citations
- 2
- FWCI
- 4.21
- Field percentile
- top 13%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The role of opioid receptors in tianeptine-induced beta oscillations and memory enhancement
Margarida Trigo, Tegan S. Knott, … Stephen J. Martin·bioRxiv·May 13, 2026
- The atypical antidepressant and cognitive enhancer tianeptine disinhibits hippocampal CA1 pyramidal neurons by reducing GABAergic neurotransmission
Stephen J. Martin, Y. Li, … Delia Belelli·bioRxiv·Dec 23, 2025
- Tianeptine, but not fluoxetine, decreases avoidant behavior in a mouse model of early developmental exposure to fluoxetine
Elizabeth A. Pekarskaya, Emma S. Holt, … Sarah Canetta·Scientific ReportsPeer-reviewed·Nov 24, 2021
- Chronic antidepressant treatments rescue reduced REM sleep theta power in a rat social defeat stress model of depression
Yoshiki Matsuda, Nobuyuki Ozawa, … Yoshitaka Tatebayashi·bioRxiv·Mar 21, 2020
- Dual Hypocretin Receptor Antagonism Reduces Oxycodone Seeking During Abstinence
Kyle R. Samson, Alison R. Bashford, Rodrigo A. España·bioRxiv·Apr 5, 2025
- Dual orexin antagonist DORA-22 suppressed posttraumatic seizures and enhances GABAergic inhibition in dentate granule cells
Sruthi R Konduru, Jesse R. Isaacson, … Rama K. Maganti·bioRxiv·Apr 17, 2022